• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-7.0-120-PTX
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Stenosis (2263); Claudication (2550)
Event Date 04/27/2015
Event Type  Injury  
Manufacturer Narrative
Pma/510(k)#: p100022/s001.The ziv6-35-125-7.0-120-ptx stent of lot number c779499 was implanted in the patient and is therefore not available for evaluation.With the information provided a document based investigation was carried out.It was confirmed that images would not be available to support the complaint investigation.According to complaint information provided, the patient had pre-existing conditions including coronary artery disease, hypercholesterolemia and was a previous smoker.Restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting).Vessel injury provokes an inflammatory response that leads to (or amplifies) the restenosis process.It may be noted that the surface of the zilver ptx stent is coated with the drug paclitaxel to help prevent subsequent restenosis of the artery.It can be therefore stated that it is very unlikely that the reported restenosis could have occurred due to zilver ptx malfunction; however a definitive cause of this event cannot be determined.Due to lack of imaging no other comments can be made.There is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.It may be noted that restenosis of the stented artery is a known potential adverse event associated with placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.According to information provided pta was performed and the patient recovered.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Event Description
On (b)(6) 2012: ziv6-35-125-7.0-120-ptx x 1 + ziv6-35-125-7.0-120-ptx x 1 were placed in the left sfa of the patient.On (b)(6) 2014: restenosis in the lesion was confirmed.(the rpn or lot number of the stenosed device(s) cannot be determined.) on (b)(6) 2014: pta was performed.The patient recovered on each day.On (b)(6) 2015: restenosis in the lesion was confirmed."worsen claudication" was observed.(the rpn or lot number of the stenosed device(s) cannot be determined.) on (b)(6) 2015: pta was performed.The patient recovered.On (b)(6) 2015: restenosis in the lesion was confirmed.(the rpn or lot number of the stenosed device(s) cannot be determined.) on (b)(6) 2015: pta was performed.The patient recovered.As two zilver ptx devices are reported to be involved in this event a report has been submitted for each suspect device.The complaint information received confirmed three separate events of intervention (pta) as a result of restenosis with these devices.A separate report has been submitted for each recorded event also.Reference also related reports 3001845648-2016-00016, 3001845648-2016-00017, 3001845648-2016-00018, 3001845648-2016-00019 & 3001845648-2016-00020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
sinead quaid
o'halloran road
national technology park
limerick 
061334440
MDR Report Key5382377
MDR Text Key36468215
Report Number3001845648-2016-00021
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/25/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-7.0-120-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/27/2015
Event Location Hospital
Initial Date Manufacturer Received 12/25/2015
Initial Date FDA Received01/21/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/22/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-